Internal Medicine, Hematology & Oncology · Fontana, CA
NPI
1598832305
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
9961 Sierra Ave
Fontana, CA, 92335
Phone (909) 427-3910
Groups this clinician bills Medicare through
Medicare paid, 2024
$60K
3,930 services
Medicare patients, 2024
29
Average age 65
Drug cost, 2024
$3.3M
1,742 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Fengyu Shu prescribed most often to Medicare patients was Letrozole, with 223 prescriptions and refills. In total Fengyu Shu wrote 1,742 Medicare prescriptions that cost $3.3M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-11-29.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Letrozole Generic | 223 | 659 | 72 | $4,509 |
| Abiraterone Acetate Generic | 171 | 188 | 27 | $27K |
| Prednisone Generic | 168 | 200 | 30 | $1,234 |
| Dexamethasone Generic | 124 | 124 | 30 | $1,649 |
| Anastrozole Generic | 106 | 343 | 34 | $3,164 |
| Lenalidomide Generic | 81 | 81 | 11 | $1.0M |
| Ondansetron Hcl Generic | 77 | 77 | 43 | $630 |
| Allopurinol Generic | 67 | 212 | 25 | $775 |
| Alendronate Sodium Generic | 57 | 158 | 20 | $559 |
| Hydroxyurea Generic | 56 | 185 | 19 | $2,677 |
| Prochlorperazine Maleate Generic | 56 | 56 | 37 | $797 |
| Imatinib Mesylate Generic | 53 | 71 | Under 11 | $3,599 |
| Anagrelide Hcl Generic | 41 | 127 | 12 | $8,367 |
| Acyclovir Generic | 40 | 108 | 16 | $1,111 |
| Procrit Epoetin Alfa | 38 | 38 | Under 11 | $28K |
Brand drugs: - claims; generic drugs: 1,479 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Fengyu Shu were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.